Señales en vivo de 4978.T | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 may 2024 @ 00:55):

Stats
Volumen de hoy	432 700
Volumen promedio	523 373
Capitalización de mercado	12.52B
EPS	¥0 ( 2024-02-08 )
Próxima fecha de ganancias	( ¥-3.62 ) 2024-05-10
Last Dividend	¥0 ( N/A )
Next Dividend	¥0 ( N/A )
P/E	-54.05
ATR14	¥0.179 (0.13%)

Volumen Correlación

Largo: 0.02 (neutral)

Corto: 0.93 (very strong)

Signal:(42.708) Expect same movement, but be aware

ReproCELL Incorporated Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ReproCELL Incorporated Correlación - Moneda/Commodity

-0.67
( moderate negative )

-0.60
( weak negative )

-0.61
( weak negative )

0.23
( neutral )

-0.14
( neutral )

-0.44
( neutral )

ReproCELL Incorporated Finanzas

Annual	2022
Ingresos:	¥2.95B
Beneficio Bruto:	¥1.14B (38.64 %)
EPS:	¥-3.62

FY	2022
Ingresos:	¥2.95B
Beneficio Bruto:	¥1.14B (38.64 %)
EPS:	¥-3.62

FY	2022
Ingresos:	¥2.23B
Beneficio Bruto:	¥803.44M (35.96 %)
EPS:	¥-7.57

FY	2021
Ingresos:	¥1.29B
Beneficio Bruto:	¥482.70M (37.53 %)
EPS:	¥-11.38

Financial Reports:

No articles found.

ReproCELL Incorporated

ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.

Actualizaciones en tiempo real para ReproCELL Incorporated [4978.T]

Upcoming Earnings Alert